Replimune Group, Inc. (REPL) Nonoperating Income (Expense) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Replimune Group, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2024.
  • Replimune Group, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $3.61 M, a 10.6% decline year-over-year.
  • Replimune Group, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $19.4 M, a 529% increase year-over-year.
  • Replimune Group, Inc. annual Nonoperating Income (Expense) for 2023 was $19.4 M, a 529% increase from 2022.
  • Replimune Group, Inc. annual Nonoperating Income (Expense) for 2022 was $3.08 M, a 1009% increase from 2021.
  • Replimune Group, Inc. annual Nonoperating Income (Expense) for 2021 was $278 K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $19.4 M $3.61 M -$430 K -10.6% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-16
Q4 2023 $19.8 M $5.89 M +$3.95 M +204% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $15.9 M $3.59 M +$5.11 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $10.8 M $6.29 M +$7.67 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $3.08 M $4.04 M +$3.75 M +1285% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-16
Q4 2022 -$668 K $1.94 M +$1.92 M +7983% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 -$2.58 M -$1.52 M -$1.42 M -1310% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$1.17 M -$1.38 M -$1.45 M -2067% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $278 K $292 K -$393 K -57.4% Jan 1, 2022 Mar 31, 2022 10-K 2023-05-18
Q4 2021 $671 K $24 K +$1.53 M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 -$861 K -$108 K +$324 K +75% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1.19 M $70 K -$270 K -79.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$915 K $685 K +$89 K +14.9% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-19
Q4 2020 -$1 M -$1.51 M -$1.98 M -417% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $979 K -$432 K -$1.54 M -139% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.51 M $340 K -$1.06 M -75.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $3.57 M $596 K -$574 K -49.1% Jan 1, 2020 Mar 31, 2020 10-K 2021-05-20
Q4 2019 $4.15 M $475 K -$1.99 M -80.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $6.14 M $1.1 M +$460 K +71.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $5.68 M $1.4 M +$5.56 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $112 K $1.17 M +$1.24 M Jan 1, 2019 Mar 31, 2019 10-K 2020-06-03
Q4 2018 -$1.13 M $2.46 M +$2.09 M +552% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 -$3.22 M $643 K +$1.05 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$4.26 M -$4.17 M -$3.79 M -1008% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$473 K -$71 K Jan 1, 2018 Mar 31, 2018 10-K 2020-06-03
Q4 2017 $378 K Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$404 K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$376 K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.